Data di Pubblicazione:
2020
Abstract:
RNA-seq has revolutionized the research community approach to studying gene expression. In
fact, this technology has opened up the possibility of quantifying the expression level of all genes at
once, allowing an ex post (rather than ex ante) selection of candidates that could be interesting for a
certain study. The continuous drop in costs and the independence of library preparation protocols
from the model species, have convinced the stakeholders to invest in this technology, by creating
consortia able to produce large disease-specific datasets that, in turn, fostered transcriptomic
research at a population level. Among many others, a virtuous example in this sense is The Cancer
Genome Atlas. In a short time RNA-seq has moved from a technology to merely quantify the expression of genes to a powerful tool to: discover new transcripts (via de novo transcriptome assembly), characterize alternative splicing variants or new cell types (through single cell RNA
sequencing). Leveraging on RNA-seq for daily diagnostic activities is no longer a dream but a consolidated reality.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
RNA-seq; algorithm; software pipeline; method assessment; differenial analysis
Elenco autori:
Geraci, Filippo
Link alla scheda completa:
Pubblicato in: